Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-1-25
pubmed:abstractText
We and others have demonstrated that administration of thrombolytic agents causes the generation of thrombosis-promoting agents. At present, we have studied whether formation in vivo of excessive amounts of plasmin is responsible for the activation of coagulation in patients treated with recombinant tissue-type plasminogen activator.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0954-6928
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
371-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8261210-Aged, pubmed-meshheading:8261210-Antithrombin III, pubmed-meshheading:8261210-Blood Coagulation, pubmed-meshheading:8261210-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:8261210-Female, pubmed-meshheading:8261210-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:8261210-Fibrinolysin, pubmed-meshheading:8261210-Humans, pubmed-meshheading:8261210-Immunoelectrophoresis, Two-Dimensional, pubmed-meshheading:8261210-Male, pubmed-meshheading:8261210-Middle Aged, pubmed-meshheading:8261210-Myocardial Infarction, pubmed-meshheading:8261210-Peptide Hydrolases, pubmed-meshheading:8261210-Plasminogen, pubmed-meshheading:8261210-Prothrombin, pubmed-meshheading:8261210-Recombinant Proteins, pubmed-meshheading:8261210-Thrombolytic Therapy, pubmed-meshheading:8261210-Tissue Plasminogen Activator, pubmed-meshheading:8261210-alpha-2-Antiplasmin
pubmed:year
1993
pubmed:articleTitle
Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
pubmed:affiliation
Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't